Chronic Migraine Complicated by Medication Overuse Headache

  • Andrea Negro
  • Paolo MartellettiEmail author
Part of the Headache book series (HEAD)


F.A. is a female 43-year-old lawyer, with a 30-year history of migraine. Her mother and her identical twin sister also suffered from migraine. Her mother, who died of brain cancer at 77 years, had suffered from migraine since her menopause, with low-frequency crisis. The temporal development of her migraine in comparison with that of her twin sister has been dichotomous.


Chronic Migraine Postpartum Depression Medication Overuse Migraine Without Aura Beck Depression Inventory Score 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. 1.
    Classification Committee of the International Headache Society (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33:629–808CrossRefGoogle Scholar
  2. 2.
    Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group (2010) OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50:921–936PubMedCrossRefGoogle Scholar
  3. 3.
    Farinelli I, Dionisi I, Martelletti P (2011) Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse? Intern Emerg Med 6(1):23–28PubMedCrossRefGoogle Scholar
  4. 4.
    Gentile G, Borro M, Lala N, Missori S, Simmaco M, Martelletti P (2010) Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine. J Headache Pain 11(5):431–435PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Gentile G, Missori S, Borro M, Sebastianelli A, Simmaco M, Martelletti P (2010) Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine. J Headache Pain 11(2):151–156PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Innamorati M, Pompili M, Fiorillo M, Lala N, Negro A, Del Bono SD, Lester D, Girardi P, Martelletti P (2013) Overattachment and perceived disability in chronic migraineurs. Clin Neurol Neurosurg 115(7):954–958PubMedCrossRefGoogle Scholar
  7. 7.
    Lionetto L, Negro A, Palmisani S, Gentile G, Del Fiore MR, Mercieri M, Simmaco M, Smith T, Al-Kaisy A, Arcioni R, Martelletti P (2012) Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs 17(3):393–406PubMedCrossRefGoogle Scholar
  8. 8.
    Martelletti P (2011) Dispute settlement understanding on the use of BOTOX® in chronic migraine. J Headache Pain 12:1–2PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Martelletti P, Steiner TJ (eds) (2011) Handbook of headache. Practical management. Springer, Heidelberg/New YorkGoogle Scholar
  10. 10.
    Negro A, D’Alonzo L, Martelletti P (2010) Chronic migraine: comorbidities, risk factors, and rehabilitation. Intern Emerg Med 5(Suppl 1):S13–S19PubMedCrossRefGoogle Scholar
  11. 11.
    Negro A, Martelletti P (2011) Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain 12(6):593–601PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Negro A, Rocchietti-March M, Fiorillo M, Martelletti P (2011) Chronic migraine: current concepts and ongoing treatments. Eur Rev Med Pharmacol Sci 5(12):1401–1420Google Scholar
  13. 13.
    Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D, Forte A, Girardi N, De Filippis S, Tatarelli R, Martelletti P (2010) Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat 7(6):81–91CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Department of Clinical and Molecular MedicineSapienza University of Rome and Regional Referral Headache Centre, Sant’Andrea HospitalRomeItaly

Personalised recommendations